"By partnering with Telenor Connexion we can significantly accelerate our entry into the global market. When evaluating M2M service providers, Telenor Connexion stood out due to its global coverage footprint, especially in key markets where people are increasingly affected by diabetes, as well as Telenor's network redundancy, and its reliable and secure services", says Jonathan Javitt, MD, MPH, CEO & Vice Chairman at Telcare.
"mHealth is much more than putting a computer between the doctor and the patient. It's about connecting patients in real-time with their caregiver and giving them immediate and accurate data on which to take clinical action. Telenor Connexion has more than 12 years' experience of connecting business and life critical applications, and the flexibility and quality of our services allow our clients to maximize patient acceptance, satisfaction and compliance, says Per Simonsen, CEO at Telenor Connexion.
Telenor Connexion provides managed connectivity and services for Telcare's comprehensive diabetes solution. The Telcare wireless glucose meter with two-way messaging transmits to an FDA-cleared back-end clinical server and a suite of smartphone apps in order to provide a complete ecosystem of care. The server connects directly to electronic medical record systems, while the phone apps are used by parents of children with diabetes and those caring for elderly people with diabetes. The solution is FDA- and HIPAA- compliant.
The Telcare platform is currently being implemented by health insurers and employers who currently care for more than 1 million people with diabetes.
Worldwide, there are more that 100 million addressable patients with diabetes, 28 million of whom are in the U.S. Current global sales for diabetes testing solutions exceed $12 billion. All U.S. health insurers, both public and private, and all EU, Canadian, and GCC health insurers reimburse for diabetes testing.
Telenor Connexion will be showcasing Telcare's innovative diabetes solution at the mHealth Summit in Washington D.C. on December 3-5. Please visit the GSMA stand 311.
About Telcare Inc.
Telcare, Inc. uses cellular technology and social networking to bridge the last mile between patients with diabetes, their caregivers, and their families in order to transform the care of chronic illness. The Company's first product, a wireless Blood Glucose Monitoring System was launched in February 2012. Telcare has been awarded two First Place E-Tech awards by CTIA, been named the MEDTEC startup of the year, been awarded the Triple Tree Award at the Wireless Life Sciences Allianceand been awarded the 2012 Edison Gold Award. Telcare's products have been featured in the Wall Street Journal, the New York Times, Forbes, Fox News, and numerous other media sources. The Company was founded in 2008 by David Bjork, John R. Dwyer, Jr., and Jonathan C. Javitt, M.D., M.P.H. For more information, visit www.telcare.com